HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Thomas Powles; Aarti Bhatia; Barbara Burtness; Takahiro Kogawa; Tomohiro Nishina; Izuma Nakayama; Christos Fountzilas; Dani R. Castillo; Meredith McKean; Funda Meric-Bernstam; James W. Smithy; Jérome Fayette; Sunandana Chandra; Fan Jin; Graham Clinthorne; Ariel E. Aguilo; Hidetoshi Hayashi

doi:10.1080/14796694.2025.2561539

HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors

Thomas Powles & Hidetoshi Hayashi et al. · 2025-10-14

NCI NIH HHS

P30 CA008748

HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors

Links

Journal

Institutions

Authors

Funding